Saudi Crown Prince Says Muslim Brotherhood ‘Very Dangerous’

Saudi Crown Prince Mohammed bin Salman attends the Future Investment Initiative conference in Riyadh, Saudi Arabia October 24, 2017. Reuters
Saudi Crown Prince Mohammed bin Salman attends the Future Investment Initiative conference in Riyadh, Saudi Arabia October 24, 2017. Reuters
TT

Saudi Crown Prince Says Muslim Brotherhood ‘Very Dangerous’

Saudi Crown Prince Mohammed bin Salman attends the Future Investment Initiative conference in Riyadh, Saudi Arabia October 24, 2017. Reuters
Saudi Crown Prince Mohammed bin Salman attends the Future Investment Initiative conference in Riyadh, Saudi Arabia October 24, 2017. Reuters

Crown Prince Mohammed bin Salman has described the Muslim Brotherhood as “very dangerous” and slammed Iran for being behind the problems of the Middle East.

“Saudi Arabia is the biggest victim of the extremist ideology,” he told TIME magazine in an interview.

“All the extremist organizations in Saudi Arabia, we treat them as terrorist organizations, like the Muslim Brotherhood. They are very dangerous, and they are classified in Saudi Arabia, Egypt, UAE and a lot of countries in the Middle East as a terrorist organization,” the Crown Prince said.

“They’re not in the Middle East because they know that the Middle East is taking good strategy against them in Saudi Arabia, Egypt, UAE, Jordan, and a lot of countries. Their main target is to radicalize Muslim communities in Europe.”

Asked about Tehran, the Crown Prince said: “If you see any problem in the Middle East, you will find Iran.”

But he stressed that the Iranian regime is “not a big threat to Saudi Arabia.”

“We might disagree on … some of (former) President (Barack) Obama’s views, but also we agree on a lot of things. So we worked together to fight terrorism with President Obama in the beginning of 2016 we had the same views of the Iranian regime and the danger of the Iranian regime. The only difference was in the tactics of how we should deal with that evil narrative of the Iranian regime,” the Crown Prince told TIME.

“So it’s not a big difference. We are aligned 99 percent. The difference is only 1 percent. But, you know, people try to focus on the 1 percent and avoid the 99 percent that we agreed on,” he added.

About his ties with President Donald Trump, the Crown Prince told his interviewer: “Of course we have a good relationship with President Trump, with his team, with his family, with all the key people in his administration, and also we have a very good relationship with many members of Congress from both parties and a lot of people in the United States of America.”

“Everyone believes in the importance of both countries to face the dangers facing us and also to continue growing and getting a better future for both countries,” he stated.

On the war in Yemen, the Crown Prince said the Iran-backed Houthis don’t think about Yemen’s interests. “They only care about their ideology, the Iranian ideology, the Hezbollah ideology.”

Asked if the Arab Coalition would use ground troops in Yemen, he said: “It’s a battle between Yemeni people, Yemeni government trying to get rid of the terrorists who hijacked their country and their normal life. And it’s their battle.”

“Whatever they ask us in Saudi Arabia or the other 12 countries in the coalition, we’ll provide. Until today they didn’t ask for soldiers on the ground,” he added.

“The humanitarian problem in Yemen didn’t start in 2015. It started in 2014 when the Houthis started to move,” the Crown Prince said in response to a question on war casualties.

“We are the biggest donor in the history of Yemen. We are still doing our best to be sure that the humanitarian need in Yemen and the interests of the people, health care, education, whatever, it’s supported,” he added.

On the peace process, he told his interviewer that “the people of Palestine know best their ways.”

He said Riyadh always tells Palestinian president Mahmoud Abbas “that whatever you think is good for you, we will support it.”

“We cannot have a relation with Israel before solving the peace issue,” he added.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.